Gastric cancer: genes and variants

Explore variant evidence for Gastric cancer across 21 analyzed proteins (MUTYH, FGFR2, ERBB2, EPCAM, PIK3CA and 16 more). Linked ClinVar records include 19 pathogenic or likely pathogenic variants, 88 variants of uncertain significance and 51 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Gastric cancer

Weakly linked (only a few uncertain records): IL1RN, ATP6V1A, FAT2 and MCM5.

ClinVar pathogenic and likely pathogenic variants linked to Gastric cancer

VariantPositionProtein partClinical label
MUTYH R242C242Pathogenic / likely pathogenic (★★)
MUTYH R242H242Pathogenic / likely pathogenic (★★)
FGFR2 W290C290Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 E565G565Protein kinasePathogenic / likely pathogenic (★★)
MUTYH W128R128Pathogenic / likely pathogenic (★★)
MUTYH R179H179Pathogenic / likely pathogenic (★★)
MUTYH R238W238Pathogenic / likely pathogenic (★★)
MUTYH V243F243Pathogenic / likely pathogenic (★★)
MUTYH G273E273Pathogenic / likely pathogenic (★★)
MUTYH G283E283Pathogenic / likely pathogenic (★★)
PIK3CA R38H38PI3K-ABDPathogenic / likely pathogenic (★★)
TP53 I251L251DNA bindingPathogenic / likely pathogenic (★★)
MUTYH P402L402Nudix hydrolasePathogenic / likely pathogenic (★★)
MUTYH R271W271Pathogenic / likely pathogenic (★★)
EPCAM M1I1Pathogenic / likely pathogenic
PALB2 M1K1Required for its oligomerization and is importanPathogenic / likely pathogenic
ERBB2 G776S776Protein kinasePathogenic / likely pathogenic
MSH6 V80I80Pathogenic / likely pathogenic
MUTYH Q411R411Nudix hydrolasePathogenic / likely pathogenic

Which prediction tools work for Gastric cancer

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Gastric cancer

Frequently asked questions

Which genes have records linked to Gastric cancer?

This view contains 21 analyzed proteins: MUTYH, FGFR2, ERBB2, EPCAM, PIK3CA and 16 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 19 pathogenic or likely pathogenic variants, 88 variants of uncertain significance and 51 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 191 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center